These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20484960)

  • 1. Pre-diagnostic levels of anionic trypsinogen, cationic trypsinogen, and pancreatic secretory trypsin inhibitor in relation to pancreatic cancer risk.
    Johansen D; Manjer J; Regner S; Lindkvist B
    Pancreatology; 2010; 10(2-3):229-37. PubMed ID: 20484960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of Helicobacter pylori in relation to the risk for pancreatic cancer.
    Lindkvist B; Johansen D; Borgström A; Manjer J
    BMC Cancer; 2008 Nov; 8():321. PubMed ID: 18986545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different markers of alcohol consumption, smoking and body mass index in relation to risk of pancreatic cancer. A prospective cohort study within the Malmö Preventive Project.
    Johansen D; Borgström A; Lindkvist B; Manjer J
    Pancreatology; 2009; 9(5):677-86. PubMed ID: 19684432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased secretion of the pancreatic secretory trypsin inhibitor (PSTI-I, monitor peptide) during development of chronic pancreatitis in the WBN/Kob rat.
    Graf R; Schiesser M; Bimmler D
    Pancreatology; 2002; 2(2):108-15. PubMed ID: 12123090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum immunoreactive cationic trypsinogen response to secretin in normal subjects.
    Andriulli A; Masoero G; Amato A; Felder M; Benitti V; Dobrilla G; De La Pierre M; Verme G
    Am J Gastroenterol; 1983 Sep; 78(9):579-83. PubMed ID: 6613971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coffee and alcohol consumption and the risk of pancreatic cancer in two prospective United States cohorts.
    Michaud DS; Giovannucci E; Willett WC; Colditz GA; Fuchs CS
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):429-37. PubMed ID: 11352851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative differential diagnosis of benign and malignant pancreatic lesions--the value of pancreatic secretory trypsin inhibitor, procarboxypeptidase B, CA19-9 and CEA.
    Cerwenka H; Aigner R; Quehenberger F; Werkgartner G; Bacher H; Hauser H; Mischinger HJ
    Hepatogastroenterology; 1997; 44(16):1117-21. PubMed ID: 9261609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Serine Peptidase Inhibitor Kazal-Type 1, Trypsinogens 1 to 3, and Complex of Trypsin 2 and α1-Antitrypsin in the Diagnosis of Severe Acute Pancreatitis.
    Rainio M; Lindström O; Penttilä A; Itkonen O; Kemppainen E; Stenman UH; Kylänpää L
    Pancreas; 2019 Mar; 48(3):374-380. PubMed ID: 30747826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pancreatic secretory trypsin inhibitor in urothelial cancer].
    Tashiro K; Torii S; Iwamuro S; Ohishi Y; Hasegawa N; Kawashima Y; Mochizuki A; Yoshigoe H; Wada T; Machida T
    Hinyokika Kiyo; 1989 Oct; 35(10):1659-63. PubMed ID: 2610172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early sequential changes in serum markers of acute pancreatitis induced by endoscopic retrograde cholangiopancreatography.
    Lempinen M; Stenman UH; Halttunen J; Puolakkainen P; Haapiainen R; Kemppainen E
    Pancreatology; 2005; 5(2-3):157-64. PubMed ID: 15849486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical distribution of trypsinogen and pancreatic secretory trypsin inhibitor in normal and neoplastic tissues in man.
    Marks WH; Ohlsson K; Polling A
    Scand J Gastroenterol; 1984 Jul; 19(5):673-6. PubMed ID: 6382569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemistry and clinical role of trypsinogens and pancreatic secretory trypsin inhibitor.
    Paju A; Stenman UH
    Crit Rev Clin Lab Sci; 2006; 43(2):103-42. PubMed ID: 16517420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tobacco smoking, alcohol consumption and pancreatic cancer risk: a case-control study in Italy.
    Talamini R; Polesel J; Gallus S; Dal Maso L; Zucchetto A; Negri E; Bosetti C; Lucenteforte E; Boz G; Franceschi S; Serraino D; La Vecchia C
    Eur J Cancer; 2010 Jan; 46(2):370-6. PubMed ID: 19782561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A loss-of-function p.G191R variant in the anionic trypsinogen (PRSS2) gene in Japanese patients with pancreatic disorders.
    Kume K; Masamune A; Takagi Y; Kikuta K; Watanabe T; Satoh K; Satoh A; Hirota M; Hamada S; Shimosegawa T
    Gut; 2009 Jun; 58(6):820-4. PubMed ID: 19052022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the relative contribution of three genes-the cystic fibrosis transmembrane conductance regulator gene, the cationic trypsinogen gene, and the pancreatic secretory trypsin inhibitor gene-to the etiology of idiopathic chronic pancreatitis.
    Audrézet MP; Chen JM; Le Maréchal C; Ruszniewski P; Robaszkiewicz M; Raguénès O; Quéré I; Scotet V; Férec C
    Eur J Hum Genet; 2002 Feb; 10(2):100-6. PubMed ID: 11938439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer.
    Li D; Ahmed M; Li Y; Jiao L; Chou TH; Wolff RA; Lenzi R; Evans DB; Bondy ML; Pisters PW; Abbruzzese JL; Hassan MM
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1470-6. PubMed ID: 15941958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2).
    Teich N; Le Maréchal C; Kukor Z; Caca K; Witzigmann H; Chen JM; Tóth M; Mössner J; Keim V; Férec C; Sahin-Tóth M
    Hum Mutat; 2004 Jan; 23(1):22-31. PubMed ID: 14695529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour-associated trypsin inhibitor TATI is a prognostic marker in colorectal cancer.
    Koskensalo S; Hagström J; Louhimo J; Stenman UH; Haglund C
    Oncology; 2012; 82(4):234-41. PubMed ID: 22508321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation analysis of the cationic trypsinogen gene in patients with pancreatic cancer.
    Hengstler JG; Bauer A; Wolf HK; Bulitta CJ; Tanner B; Oesch F; Gebhard S; Boettger T
    Anticancer Res; 2000; 20(5A):2967-74. PubMed ID: 11062709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Smoking, consumption of alcoholic beverages and coffee as factors associated with the development of cancer of the pancreas].
    Pfeffer F; Avilas Rosas H; Vargas F; Villalobos JJ
    Rev Invest Clin; 1989; 41(3):205-8. PubMed ID: 2813993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.